Monosomy 1p36 uncovers a role for OX40 in survival of activated CD4+ T cells

Clin Immunol. 2008 Aug;128(2):181-9. doi: 10.1016/j.clim.2008.03.522. Epub 2008 Jun 3.

Abstract

Monosomy 1p36 is a subtelomeric deletion syndrome associated with congenital anomalies presumably due to haploinsufficiency of multiple genes. Although immunodeficiency has not been reported, genes encoding costimulatory molecules of the TNF receptor superfamily (TNFRSF) are within 1p36 and may be affected. In one patient with monosomy 1p36, comparative genome hybridization and fluorescence in- situ hybridization confirmed that TNFRSF member OX40 was included within the subtelomeric deletion. T cells from this patient had decreased OX40 expression after stimulation. Specific, ex vivo T cell activation through OX40 revealed enhanced proliferation, and reduced viability of patient CD4+ T cells, providing evidence for the association of monosomy 1p36 with reduced OX40 expression, and decreased OX40-induced T cell survival. These results support a role for OX40 in human immunity, and calls attention to the potential for haploinsufficiency deletions of TNFRSF costimulatory molecules in monosomy 1p36.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4-Positive T-Lymphocytes / immunology*
  • Child, Preschool
  • Chromosomes, Human, Pair 1 / genetics
  • Female
  • Gene Deletion
  • Humans
  • Lymphocyte Activation
  • Monosomy / immunology*
  • Receptors, OX40 / physiology*

Substances

  • Receptors, OX40